Phase Ib Study of Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Disease Sites:

Leukemia, Myelodysplastic Syndrome, Phase I

Staging:

Phase I

Age Group:

Adults

Therapies:

Mol. targeted/Immunotherapy/Biologics

Drugs:

Not Available

Principal Investigator(s):

Ball, Somedeb

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

07-29-2024

Trial Type:

Treatment

Protocol ID:

VICC-VCHEM23008P

National Clinical Trial ID:

NCT06399640

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available